Back to Search Start Over

Reply

Authors :
Elie A. Akl
E. William St. Clair
Joan M. Bathon
Bryant R. England
Liana Fraenkel
Source :
Arthritis & Rheumatology. 74:175-175
Publication Year :
2021
Publisher :
Wiley, 2021.

Abstract

We thank Dr. Evangelatos for his interest in the guideline and his efforts to provide further clarity to this clinical scenario. During the guideline process, the voting panel thoroughly discussed many of these aspects of hypogammaglobulinemia during rituximab treatment that Dr. Evangelatos has adeptly described.

Details

ISSN :
23265205 and 23265191
Volume :
74
Database :
OpenAIRE
Journal :
Arthritis & Rheumatology
Accession number :
edsair.doi.dedup.....6111015d425b7b588eeeb8d292a228de